News

FDA recall medical device recall product recall

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications.

Cereglide 57 image courtesy of Johnson & Johnson MedTech.

Johnson & Johnson launches 3 new stroke devices

These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.

artificial intelligence AI policy washington capitol

Radiology artificial intelligence firm asks FDA to exempt certain devices from premarket review

The petition from Harrison.ai has drawn mixed reactions, with AI vendors lending support while radiologists and patient groups worry the move could erode safety.

money brain artificial intelligence dollars

RadNet acquires radiology AI firm Gleamer for up to $270M

The Los Angeles-based imaging group believes the move will make its DeepHealth subsidiary the “largest provider of radiology clinical AI solutions worldwide.”

Nuclear medicine firm Shine Technologies raises $240M

Surgeon, researcher and billionaire entrepreneur Patrick Soon-Shiong, MD, and his company NantWorks led the funding round with participation from several others.

AHA: ‘Zero trust’ cybersecurity posture necessary to protect hospital data

The National Security Agency released a two-phase plan for all entities within the U.S. Department of War to follow for no-trust cyber defenses. The American Hospital Association said the protocols could be adopted by hospitals.

doctor comparing the costs of different medical treatments

Hospitals accounted for 40% of spike in healthcare spending, far more than any other category: KFF

The study by the nonprofit KFF is focused on the jump in overall healthcare prices from 2022 to 2024, with hospitals leading as a result of both delayed care from the pandemic and an increase in prices for services.

Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.

FDA approves next-generation CardioMEMS reader for heart failure monitoring

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure.

Obicetrapib linked to substantial reductions in LDL cholesterol for high-risk heart patients

Researchers shared new studies on the highly selective CETP inhibitor in The New England Journal of Medicine and The Lancet.

'Watching patients suffer': Radiology workers say staff shortage costing lives

A circulating letter signed by IR techs and nurses details concerns about how a dire shortage of qualified staff is impacting care at a regional hospital.

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

TAVR and SAVR deliver similar outcomes for patients with low-flow, low-gradient aortic stenosis

Paravalvular leak was more common after TAVR, as one may expect, but that was the only notable difference between the two aortic valve replacement strategies. The study's authors did highlight the importance of additional research, including larger studies with longer follow-up periods.

Around the web

Cardiovascular Business

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications.